Efficacy and Safety Study of Deferasirox in Patients With Non-transfusion Dependent Thalassemia

NCT01709838 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

134

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-transfusion Dependent Thalassemia

Interventions

DRUG: deferasirox

Sponsor

Novartis Pharmaceuticals